# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Oppenheimer analyst Francois Brisebois reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Outperform and maintains $11 pr...
Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate ...
Oppenheimer analyst Francois Brisebois maintains Achieve Life Sciences (NASDAQ:ACHV) with a Outperform and lowers the price ...
Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate ...